Predictors of reaching a serum uric acid goal in patients with gout and treated with febuxostat

Richard Sheer1 Comprehensive Health Insights, Inc., Louisville, KY

Kyle D Null2 Takeda Pharmaceuticals U.S.A., Inc., Deerfield, IL, USA

Keith A Szymanski2 Takeda Pharmaceuticals U.S.A., Inc., Deerfield, IL, USA

Lavanya Sudharshan1 Comprehensive Health Insights, Inc., Louisville, KYCorrespondence[email protected]

Jennifer Banovic2 Takeda Pharmaceuticals U.S.A., Inc., Deerfield, IL, USA

Margaret K Pasquale1 Comprehensive Health Insights, Inc., Louisville, KY

Pages 629-639 | Published online: 10 Oct 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

ZhuYPandyaBJChoiHKPrevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008Arthritis Rheum201163103136314121800283
PubMed Web of Science ®Google Scholar
JuraschekSPKovellLCMillerER3rdGelberACGout, urate-lowering therapy, and uric acid levels among adults in the United StatesArthritis Care Res (Hoboken)201567458859225201123
PubMed Web of Science ®Google Scholar
SarawateCAPatelPASchumacherHRYangWBrewerKKBakstAWSerum urate levels and gout flares: analysis from managed care dataJ Clin Rheumatol2006122616516601538
PubMed Web of Science ®Google Scholar
Perez-RuizFTreating to target: a strategy to cure goutRheumatology (Oxford)200948Suppl 2ii9ii1419447780
PubMed Web of Science ®Google Scholar
KhannaDFitzgeraldJDKhannaPPAmerican College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemiaArthritis Care Res (Hoboken)201264101431144623024028
PubMed Web of Science ®Google Scholar
TsurutaYMochizukiTMoriyamaTSwitching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney diseaseClin Rheumatol201433111643164825048744
PubMed Web of Science ®Google Scholar
WheltonAMacDonaldPAChefoSGunawardhanaLPreservation of renal function during gout treatment with febuxostat: a quantitative studyPostgrad Med2013125110611423391676
PubMed Web of Science ®Google Scholar
MitriGWittbrodtETTurpinRSTidwellBASchulmanKLCost comparison of urate-lowering therapies in patients with gout and moderate-to-severe chronic kidney diseaseJ Manag Care Spec Pharm201622432633627023686
PubMed Web of Science ®Google Scholar
HatoumHKhannaDLinSJAkhrasKSShiozawaAKhannaPAchieving serum urate goal: a comparative effectiveness study between allopurinol and febuxostatPostgrad Med20141262657524685969
PubMed Web of Science ®Google Scholar
KimSCSchmidtBMFranklinJMLiuJSolomonDHSchneeweissSClinical and health care use characteristics of patients newly starting allopurinol, febuxostat, and colchicine for the treatment of goutArthritis Care Res (Hoboken)201365122008201423861232
PubMed Web of Science ®Google Scholar
DeyoRACherkinDCCiolMAAdapting a clinical comorbidity index for use with ICD-9 CM administrative databasesJ Clin Epidemiol19924566136191607900
PubMed Web of Science ®Google Scholar
FarleyJFHarleyCDevineJWA comparison of comorbidity measurements to predict healthcare expendituresAm J Manag Care20061211011716464140
PubMed Web of Science ®Google Scholar
SloanKLSalesAELiuCFConstruction and characteristics of the RxRisk-V: a VA-adapted pharmacy-based case-mix instrumentMed Care200341676177412773842
PubMed Web of Science ®Google Scholar
SinghJAAkhrasKSShiozawaAComparative effectiveness of urate lowering with febuxostat vs. allopurinol in gout: analyses from large U.S. managed care cohortArthritis Res Ther201517112025963969
PubMed Web of Science ®Google Scholar
RiedelAANelsonMJoseph-RidgeNWallaceKMacDonaldPBeckerMCompliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claimsJ Rheumatol20043181575158115290738
PubMed Web of Science ®Google Scholar
AltanAShiozawaABancroftTSinghJAA real-world study of switching from allopurinol to febuxostat in a health plan databaseJ Clin Rheumatol201521841141826580304
PubMed Web of Science ®Google Scholar
SarawateCABrewerKKYangWGout medication treatment patterns and adherence to standards of care from a managed care perspectiveMayo Clin Proc200681792593416835972
PubMed Web of Science ®Google Scholar
HarroldLRAndradeSEBriesacherBAAdherence with urate-lowering therapies for the treatment of goutArthritis Res Ther2009112R4619327147
PubMed Web of Science ®Google Scholar
McGowanBBennettKSilkeCWhelanBAdherence and persistence to urate-lowering therapies in the Irish settingClin Rheumatol201635371572125409858
PubMed Web of Science ®Google Scholar
De VeraMAMarcotteGRaiSGaloJSBholeVMedication adherence in gout: a systematic reviewArthritis Care Res (Hoboken)201466101551155924692321
PubMed Web of Science ®Google Scholar
BeckerMAMacDonaldPAHuntBJJacksonRLDiabetes and gout: efficacy and safety of febuxostat and allopurinolDiabetes Obes Metab201315111049105523683134
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Predictors of reaching a serum uric acid goal in patients with gout and treated with febuxostat

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Predictors of reaching a serum uric acid goal in patients with gout and treated with febuxostat

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date